|
MACK
|
Merrimack Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
MBRX
|
Moleculin Biotech, Inc.
|
US
|
NASDAQ
|
|
MRSN
|
Mersana Therapeutics, Inc.
|
US
|
NASDAQ
|
|
OPK
|
OPKO Health Inc.
|
US
|
NASDAQ
|
|
ORIC
|
Oric Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
SGEN
|
Seattle Genetics, Inc.
|
US
|
NASDAQ
|
|
SPPI
|
Spectrum Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
URGN
|
UroGen Pharma Ltd.
|
US
|
NASDAQ
|
|
VERU
|
Veru Inc.
|
US
|
NASDAQ
|
|
VNDA
|
Vanda Pharmaceuticals Inc.
|
US
|
NASDAQ
|
|
ATX
|
Amplia Therapeutics Limited
|
AU
|
ASX
|
|
KZA
|
Kazia Therapeutics Limited
|
AU
|
ASX
|
|
NOX
|
Noxopharm Ltd
|
AU
|
ASX
|
|
RAC
|
Race Oncology Ltd
|
AU
|
ASX
|
|
RCE
|
Recce Ltd
|
AU
|
ASX
|
|
BICTF
|
Biocure Technology Inc
|
US
|
OTC
|
|
BIOYF
|
Biosyent Inc
|
US
|
OTC
|
|
CHJTF
|
CSPC Pharma Group
|
US
|
OTC
|
|
CYTR
|
Cytrx Corporation
|
US
|
OTC
|
|
DIZTF
|
Dignitana Ab
|
US
|
OTC
|